Embecta Corp (EMBC) stock price

Embecta Corp (EMBC) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $5.19 (+0.00%), Market cap $0.19B, P/E ratio 1.66, 52-week low–high $3.12 ~ $15.31.

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Embecta Corp are updated in real time on BlackAll Trade.

Embecta Corp financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Embecta Corp (EMBC) stock price?

Embecta Corp trades at $5.19 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.

What is the Embecta Corp (EMBC) market cap?

Embecta Corp has a market cap of about $0.19B. Its P/E ratio is 1.66.

What does Embecta Corp (EMBC) do?

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include